These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18789343)

  • 1. Frontiers in addiction research: celebrating the 35th anniversary of the National Institute on Drug Abuse. Sponsor's foreword.
    Shurtleff D; Liu R; Sasek C
    Neuropharmacology; 2009; 56 Suppl 1():1-2. PubMed ID: 18789343
    [No Abstract]   [Full Text] [Related]  

  • 2. Plan for addiction institute splits NIH.
    Wadman M
    Nature; 2010 Oct; 467(7316):643. PubMed ID: 20930813
    [No Abstract]   [Full Text] [Related]  

  • 3. Blending addiction research and practice: strategies for technology transfer.
    Condon TP; Miner LL; Balmer CW; Pintello D
    J Subst Abuse Treat; 2008 Sep; 35(2):156-60. PubMed ID: 18337054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congratulations on the 10-year anniversary of the National Drug Abuse Treatment Clinical Trial Network--now, what's new for the coming decade?
    McLellan AT
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1():S1-3. PubMed ID: 20307790
    [No Abstract]   [Full Text] [Related]  

  • 5. Reflecting on 30 years of research. A look at how NIDA has advanced the research, prevention, and treatment of drug abuse and addiction.
    Condon TP
    Behav Healthc; 2006 May; 26(5):14, 16. PubMed ID: 16736912
    [No Abstract]   [Full Text] [Related]  

  • 6. Sponsor's foreword: NIDA at forty.
    Shurtleff D; Sasek C; Kautz M
    Neuropharmacology; 2014 Jan; 76 Pt B():195-7. PubMed ID: 23994442
    [No Abstract]   [Full Text] [Related]  

  • 7. Sex-gender differences in drug abuse: a shift in the burden of proof?
    Wetherington CL
    Exp Clin Psychopharmacol; 2007 Oct; 15(5):411-7. PubMed ID: 17924775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inaugural special issue in research translation.
    Tarter R
    Am J Drug Alcohol Abuse; 2009; 35(4):205. PubMed ID: 20180670
    [No Abstract]   [Full Text] [Related]  

  • 9. Planning the new national institute on substance use and addiction disorders.
    Nestler EJ; Krystal JH
    Biol Psychiatry; 2012 Aug; 72(3):166-7. PubMed ID: 22683089
    [No Abstract]   [Full Text] [Related]  

  • 10. Partnerships in drug abuse prevention services research: perspectives from the National Institute on Drug Abuse.
    Robertson EB; Sims BE; Reider EE
    Adm Policy Ment Health; 2012 Jul; 39(4):327-30. PubMed ID: 22203328
    [No Abstract]   [Full Text] [Related]  

  • 11. The 40th anniversary of the National Institute on Alcoholism and Alcohol Abuse: the impact on liver disease.
    Szabo G
    Hepatology; 2010 Jul; 52(1):10-2. PubMed ID: 20578124
    [No Abstract]   [Full Text] [Related]  

  • 12. What's in a name? Proposed name changes of the US National Institute on Drug Abuse and the US National Institute on Alcohol Abuse and Alcoholism.
    Midanik LT
    Addiction; 2008 Jan; 103(1):1-3. PubMed ID: 18081607
    [No Abstract]   [Full Text] [Related]  

  • 13. National Institutes of Health. Collins endorses merger of U.S. addiction research programs.
    Kaiser J
    Science; 2010 Nov; 330(6008):1166. PubMed ID: 21109640
    [No Abstract]   [Full Text] [Related]  

  • 14. The National Institute on Drug Abuse 1992--focus on the future: a steadfast commitment to research.
    Millstein RA
    NIDA Res Monogr; 1993; 132():9-17. PubMed ID: 8341375
    [No Abstract]   [Full Text] [Related]  

  • 15. The National Institute on Drug Abuse 1991: new faces, responsibilities, and opportunities.
    Schuster CR
    NIDA Res Monogr; 1992; 119():3-9. PubMed ID: 1435979
    [No Abstract]   [Full Text] [Related]  

  • 16. Human neuroscience at National Institute on Drug Abuse: implications for genetics research.
    Gordon HW
    Am J Med Genet; 1994 Dec; 54(4):300-3. PubMed ID: 7726199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blending research and practice: an evolving dissemination strategy in substance abuse.
    Michel ME; Pintello DA; Subramaniam G
    Soc Work Public Health; 2013; 28(3-4):302-12. PubMed ID: 23731421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research.
    Fauci AS;
    J Infect Dis; 2008 Jun; 197(11):1493-8. PubMed ID: 18426366
    [No Abstract]   [Full Text] [Related]  

  • 19. The acquisition of drug abuse information for the National Clearinghouse for Drug Abuse Information.
    Lachter SB
    Drug Inf J; 1975; 9(2-3):195-8. PubMed ID: 10316630
    [No Abstract]   [Full Text] [Related]  

  • 20. The ambitions and goals of the National Heart, Lung, and Blood Institute at The National Institute of Health.
    Eur Heart J; 2009 May; 30(10):1155-6. PubMed ID: 19443422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.